发明申请
US20050112702A1 Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
有权
鉴定使用CLLD8蛋白调节IL-4受体介导的IgE合成的化合物的方法
- 专利标题： Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
- 专利标题（中）： 鉴定使用CLLD8蛋白调节IL-4受体介导的IgE合成的化合物的方法
-
申请号： US11027949申请日： 2004-12-30
-
公开(公告)号： US20050112702A1公开(公告)日： 2005-05-26
- 发明人: Esteban Masuda , Todd Kinsella , Justin Warner , Taisei Kinoshita , Mark Bennett , David Anderson
- 申请人： Esteban Masuda , Todd Kinsella , Justin Warner , Taisei Kinoshita , Mark Bennett , David Anderson
- 申请人地址： US CA South San Francisco
- 专利权人： Rigel Pharmaceuticals, Inc.
- 当前专利权人： Rigel Pharmaceuticals, Inc.
- 当前专利权人地址： US CA South San Francisco
- 主分类号： A61K38/17
- IPC分类号： A61K38/17 ; C07K7/08 ; C07K14/54 ; G01N33/68 ; G01N33/53 ; G01N33/567
摘要：
The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a CLLD8 protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
公开/授权文献
信息查询
IPC分类:
